第一医药（600833）公告，公司参与投资设立的上海创特私募投资基金合伙企业(有限合伙)已于2025年 5月13日在中国证券投资基金业协会完成备案手续，并取得《私募投资基金备案证明》，备案编码为 SAXM42。基金管理人为上海商投创业投资有限公司，托管人为华夏银行股份有限公司。公司将持续关 注基金的后续进展情况，并及时履行信息披露义务。 ...

Group 1 - The company has announced its participation in the establishment of the Shanghai Chuangte Private Investment Fund Partnership (Limited Partnership), which has completed its business registration [1] - The fund has a total scale of 56 million yuan, with an initial capital contribution of 10 million yuan [1] - As of the announcement date, the initial capital contribution has been completed, with the following contributions from partners: Shanghai Shengtou Venture Capital Co., Ltd. (GP, manager) 1 million yuan, Shanghai Bailian Guotai Junan Chuangling Private Fund Partnership (Limited Partnership) 6 million yuan, Shanghai First Pharmaceutical Co., Ltd. (LP) 1 million yuan, Shanghai Fengxian Biotechnology Park Development Co., Ltd. (LP) 1 million yuan, and Huai'an Kechuang Industrial Investment Co., Ltd. (LP) 1 million yuan, totaling 10 million yuan [1]